Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita

8 Jun 2013

Abstract excerpt

We describe outcomes after allogeneic transplantation in 34 patients with dyskeratosis congenita who underwent transplantation between 1981 and 2009. The median age at transplantation was 13 years (range, 2 to 35). Approximately 50% of transplantations were from related donors. Bone marrow was the predominant source of stem cells (24 of 34). The day-28 probability of neutrophil recovery was 73% and the day-100...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Telomeres, Telomerase, and Senescence
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23751955
DOI: 10.1016/j.bbmt.2013.05.021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis CongenitaPMID 23751955Read ↗

Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.Semantic proximity Read ↗

The diagnosis and treatment of dyskeratosis congenita: a reviewSemantic proximity Read ↗

Outcomes of Dyskeratosis Congenita: Results From the Canadian Inherited Marrow Failure Registry.Semantic proximity Read ↗

Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantationSemantic proximity Read ↗

Autoimmune Complications after Hematopoietic Stem Cell Transplantation in Children with Nonmalignant DisordersSemantic proximity Read ↗

Reduced‐intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenitaSemantic proximity Read ↗

Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1.Semantic proximity Read ↗

Cancer in dyskeratosis congenita.Semantic proximity Read ↗

Outcomes of Hematopoietic Stem Cell Transplantation in 5 Patients with Autosomal Recessive RIPK1-Deficiency.Semantic proximity Read ↗

Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disordersSemantic proximity Read ↗

Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita.Semantic proximity Read ↗

Late-onset dyskeratosis congenita due to a TERC (n.269G > C) variant-first reported case from Indonesia: a case report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.